IONICON US Starts its Operations in North America
News Oct 20, 2011
IONICON US, Inc. is a totally-owned subsidiary of Austrian-based IONICON Analytik GmbH, the world’s leading PTR-MS company since 1998. The new US subsidiary takes over the marketing and after-sales-support for the United States and Canada.
IONICON, a manufacturer of highest performance online mass spectrometers for VOC analysis based on the unique Proton Transfer Reaction - Mass Spectrometry technology (PTR-MS) and known for its superior customer support, will now increase its investment in the US market.
Co-founder of IONICON Austria and Vice-President of IONICON US, Inc. Dr. Alfons JORDAN recently moved to the US in order to start IONICON US. He is eager to turn his challenging assignment into success: “I will be the first point of contact for all inquiries from the US and I am looking forward to be in touch with all our US customers and people interested in our products. For demonstrations we have an IONICON High-Sensitivity PTR-MS available in a nearby lab which can be used for showcases and tests of samples.”
IONICON CEO Lukas MÄRK is looking forward to the start-up of operations at IONICON US: “This will improve the user experience as one of our most experienced PTR-MS experts is now residing in New Jersey and is available for inquiries, customer showcases and professional after-sales-service.”
Since the first sale of an IONICON PTR-MS to the US in 2000, more than 40 systems have been exported to IONICON’s most important market outside of Europe.
Lukas MÄRK comments on the company’s US strategy: “This investment will stimulate growth of our business in the United States, help customers to build confidence in our innovative and successful but relatively small company by showing our local presence and dedication to the United States”.
UK Not Ready for Brexit’s Impact on Food, Report WarnsNews
Severe problems with the UK food system are likely unless issues are addressed, according to latest expert reportREAD MORE
High Serum Serotonin Levels Found in Blood of SIDS InfantsNews
Findings from NIH-funded study could provide basis for forensic SIDS test.READ MORE
Advanced Cancer Drug Study Highlights Need for Novel ApproachesNews
The pre-clinical findings, just published in Cell Chemical Biology, may lay the foundation for improving therapies for treatment-resistant, aggressive prostate cancer.READ MORE
Comments | 0 ADD COMMENT
18th International Conference and Exhibition on Analytical & Bioanalytical Chromatographic Techniques
Nov 02 - Nov 03, 2017
8th Edition of International Conference on Mass Spectromerty
Mar 12 - Mar 13, 2018